Watch SPRB. Know when insiders buy.
One email the day a filing lands. Free.
SPRB
SPRUCE BIOSCIENCES, INC.
47.09
−1.63 −3.35%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
29
FLAG · shorts 29
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $135.3MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$51.4MNET CASH $76.4M52W 8.60 – 182.60SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$16.5M | −$16.2M | — | -6.68 | −$22.1M | $135K | −$22.3M | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$12M | −$12.3M | — | -8.94 | −$8.7M | $10K | −$8.7M | May 13 |
| Q4 2025 · Dec 31derived | $0 | −100.0% | — | −$11.1M | −$14.6M | — | -9.58 | −$6.5M | — | — | Mar 9 |
| Q3 2025 · Sep 30 | $0 | −100.0% | — | −$8.2M | −$8.2M | — | -14.58 | −$5.3M | — | — | Nov 10 |
| Q2 2025 · Jun 30 | $0 | −100.0% | — | −$2.7M | −$2.1M | — | -3.50 | −$8.8M | $0 | −$8.8M | Aug 12 |
| Q1 2025 · Mar 31 | $0 | −100.0% | — | −$14.5M | −$14M | — | -23.95 | −$12.7M | $0 | −$12.7M | May 13 |
| Q4 2024 · Dec 31derived | $697K | −75.9% | — | −$24.1M | −$23.6M | — | -42.72 | −$20.7M | $0 | −$20.7M | Mar 9 |
| Q3 2024 · Sep 30 | $602K | −80.4% | — | −$9.4M | −$8.7M | — | -15.75 | −$9.2M | — | — | Nov 10 |
| Q2 2024 · Jun 30 | $1.6M | — | — | −$10M | −$9.2M | — | -16.73 | −$11.1M | — | — | Aug 14 |
| Q1 2024 · Mar 31 | $2M | — | — | −$12.6M | −$11.6M | — | -0.28 | −$15M | — | — | May 6 |
| Q4 2023 · Dec 31derived | $2.9M | — | — | −$11.2M | −$9.9M | — | -0.23 | −$11.2M | $0 | −$11.2M | Apr 15 |
| Q3 2023 · Sep 30 | $3.1M | — | — | −$13.7M | −$12.4M | — | -0.30 | −$12.3M | $7K | −$12.3M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$36.5M | −$39M | — | -50.83 | −$33.3M | — | — | — | — |
| FY2024 · to Dec 31 | $4.9M | — | −$56.2M | −$53M | -1079.9% | -96.40 | −$56M | $0 | −$56M | — | — |
| FY2023 · to Dec 31 | $10.1M | — | −$52M | −$47.9M | -475.0% | -1.24 | −$33.3M | $7K | −$33.3M | — | — |
| FY2022 · to Dec 31 | $0 | — | −$47.3M | −$46.2M | — | -1.96 | −$41.7M | $8K | −$41.7M | — | — |
| FY2021 · to Dec 31 | — | — | −$42.1M | −$42.3M | — | -1.81 | −$35.9M | $93K | −$36M | — | — |
| FY2020 · to Dec 31 | — | — | −$29.4M | −$29.5M | — | -4.93 | −$27.5M | $74K | −$27.6M | — | — |
Every number comes from SPRUCE BIOSCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.